MT-Medicals' Unattributed VC Round

MT-Medicals raised a round of funding on October 09, 2017. Investors include Primer Capital.

MT-Medicals is developing treatments for drug-resistant tuberculosis.…

Articles about MT-Medicals' Unattributed VC Round: